Loading…
View analytic
Wednesday, March 6 • 9:30am - 12:30pm
The Virtual Patient – The Future of Medicine LIMITED

Log in to save this to your schedule and see who's attending!

Limited Capacity seats available

As personalised medicine enters clinical and public health practice, its wider implementation requires favourable health policies and a new health infrastructure. Personalised Medicine is expected to allow our current, largely reactive mode of medicine to be replaced over the next years by a personalised, predictive, preventive, and participatory medicine. Europe has to provide citizens with access to emerging knowledge and technologies which will aid them in achieving a better quality of life over an extended lifetime. Information and Communication Technology (ICT) has been identified as one of the bottlenecks. Due to growing demands for data-rich, individualised medicine, ICT and healthcare are increasingly merging. As data-intensive analysis and computer-intensive modelling become common practice, this will result in a shift from personnel-intensive to ICT-intensive applications. Modelling will be used to generate “Virtual Patients”, such that each citizen might conceivably have a “virtual twin” that can be used to simulate and predict outcomes such as response to therapeutic or preventive interventions. To accelerate the development of personalised medicine, personal health and individualised healthcare global collaborations of researchers in academia, industry, SMEs, patient groups and regulatory authorities are needed, preferably as public-private partnerships, to ensure that research results are translated into tangible benefits for citizens.

 

Agenda

 


Moderators
avatar for Helmut Brand

Helmut Brand

Professor European Public Health, Department of International Health at Maastricht University
Helmut Brand is a Jean Monnet Professor of European Public Health and Head of the Department of International Health at Maastricht University. He has developed a successful career combining competencies related to practice in the area of public health and management at the level... Read More →
avatar for Hans Lehrach

Hans Lehrach

Hans Lehrach obtained his Ph.D. at the Max Planck Institute for Experimental Medicine and the Max Planck Institute for Biophysical Chemistry in 1974. Next he moved on to Harvard University, Boston (1974-1978) for a postdoc and then became group leader at EMBL, Heidelberg (1978-1987... Read More →

Speakers
avatar for Peter Boyle

Peter Boyle

President of the International Prevention Research Institute, Lyon, France
Dr Boyle’s appointment as President of the International Prevention Research Institute, Lyon, France follows immediately on his tenure as Director of the International Agency for Research on Cancer (IARC/WHO) from 2004 to 2008 in Lyon, France. He previously had had a number of successive... Read More →
avatar for Angela Brand

Angela Brand

Institute for Public Health Genomics, Maastricht University, The Netherlands
Presentation topic: Personalised Healthcare – what and how to translate?   Prof. Angela Brand, MD PhD MPH (USA) is Founding Director and Full Professor of the Institute for Public Health Genomics (IPHG) at the Faculty of Health, Medicine and Life Sciences at Maastricht University... Read More →
avatar for David Byrne

David Byrne

David Byrne was appointed EU Commissioner in 1999 and held the portfolio of Health and Consumer Affairs during the Prodi Commission, when he established the European Centre for Disease Control (ECDC) and the European Food Safety Authority (EFSA). Prior to that, he served as Attorney... Read More →
avatar for Morten Ernebjerg

Morten Ernebjerg

Developer at the SAP Innovation Center Potsdam
Morten Ernebjerg got his PhD in theoretical physics from Harvard University in 2007. Fascinated by the use of modeling in biology, he then became a Postdoctoral Fellow at the Department of Systems Biology at Harvard Medical School. During his five years there, he worked on the ecology... Read More →
avatar for Magda Gunn

Magda Gunn

Scientific Manager at IMI
Magda Gunn has obtained her master’s degree in chemistry from Adam Mickiewicz University in Poznan, Poland in 2001. In 2007 she obtained her Ph.D. in chemistry from North Carolina State University in Raleigh, North Carolina, USA. | Her career continued at a biotech company SomaLogic... Read More →
avatar for Ivo Gut

Ivo Gut

Director Centre Nacional d'Anàlisi Genòmica (CNAG)
Ivo Gut is qualified in Chemistry at the University of Basel and obtained a PhD in Physical Chemistry from the same University with Prof. Jakob Wirz in 1990.  He was a Research Fellow in the group of Prof. Irene Kochevar at Harvard Medical School (1990-1993), and in the laboratory... Read More →
avatar for Walter Kolch

Walter Kolch

Director of Systems Biology Ireland
Prior to his appointment as SBI Director, Professor Walter Kolch was a Senior Group Leader at the Beatson Institute for Cancer Research, and Professor for Molecular Cell Biology at the University of Glasgow, Scotland. Walter is also Director of the UCD Conway Institute, an interdisciplinary... Read More →
avatar for Hans Lehrach

Hans Lehrach

Hans Lehrach obtained his Ph.D. at the Max Planck Institute for Experimental Medicine and the Max Planck Institute for Biophysical Chemistry in 1974. Next he moved on to Harvard University, Boston (1974-1978) for a postdoc and then became group leader at EMBL, Heidelberg (1978-1987... Read More →
avatar for Kurt Zatloukal

Kurt Zatloukal

Professor of Pathology at the Medical University of Graz, Austria
Kurt Zatloukal, M.D. is professor of Pathology at the Medical University of Graz, Austria. He coordinated the preparatory phase of the European biobanking and biomolecular research infrastructure (BBMRI-ERIC) within the 7th EU framework programme. In this context it was crucial to... Read More →


Wednesday March 6, 2013 9:30am - 12:30pm
European Parliament P5B001

Attendees (2)